Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: A primer for cardiologists and an update for the cardiothoracic team

George J. Despotis*, Charles W. Hogue

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are at increased risk for excessive perioperative blood loss requiring transfusion of blood products. The risk is dependent on the status of the patient, the type of procedure, and the duration of CPB. This brief review will summarize (1) the pathophysiology of abnormalities in the hemostatic system during CPB; (2) important pharmacologic interventions currently available to decrease blood loss, including mechanisms by which these agents lead to preservation of hemostasis during CPB; and (3) the optimal management of perioperative bleeding using point-of-care coagulation tests.

Original languageEnglish (US)
Pages (from-to)15B-30B
JournalAmerican Journal of Cardiology
Volume83
Issue number4 A
DOIs
StatePublished - Feb 18 1999

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: A primer for cardiologists and an update for the cardiothoracic team'. Together they form a unique fingerprint.

Cite this